编者按：2016年5月6日－10日，美国泌尿协会年会（American Urological Association Annual Meeting; 简称AUA）在美国圣迭戈（San Diego）顺利举行。 本届年会由美国泌尿协会主办，来自美国肯塔基大学医学院的 William F. Gee 教授为大会主席。大会聚集了世界众多泌尿领域顶级大咖，分享泌尿科最新进展和洞悉前沿研究趋势。
会议期间，笔者有幸邀请到来自美国杜克大学医学中心，并在本次会议上作为前列腺癌局部消融治疗专场主持人的 Thomas J. Polascik 教授，进行一个简单的访谈。阐述现阶段前列腺癌局部消融治疗法的进展，该治疗法的优缺点及目前面临的挑战。
图：Dr. Thomas J. Polascik 接受 AME 编辑采访
The current status of focal ablative therapies for prostate cancer
Pros and cons of focal ablative therapies for prostate cancer
How to face the challenges?
What is the follow-up care after focal ablative therapies for prostate cancer?
Do you have anything about focal ablative therapies for prostate cancer to share with our readers?
Any suggestion about focal therapies for prostate cancer for young urologists?
What would you like to choose as your career if not to be a urologist?
Thomas J. Polascik, M.D., is a Professor in the Department of Surgery, Division of Urologic Surgery and Duke Prostate Center at Duke University Medical Center.
Dr Polascik completed his medical degree from the University of Chicago in 1991. He has also completed several other postgraduate educational programs, such as a business of medicine executive program, clinical trials, residencies and internships.
Dr Polascik has gained memberships to several reputable associations, including American Urological Association, American Medical Association, Society of Urologic Oncology, North Carolina Urological Association, North Carolina Medical Society and many more. Dr Polascik has also participated in several advisory, academic and societal committees, such as the Duke Comprehensive Cancer Center, the Duke Prostate Cancer Screening Program, Southeastern Section of the AUA, North Carolina Medical Society and NCI-funded Fresh Start Project on 'Promoting Health in Prostate and Breast Cancer Survivors'.
His research interest has focused on prostate cancer imaging , focal therapy of prostate cancer, prostate cancer outcomes, minimally invasive surgery and nerve sparing cryotherapy.